Laxxon Medical - Crunchbase Company Profile & Funding

Q: Where is Laxxon Medical's headquarters?

Laxxon Medical is located in Zürich, Zurich, Switzerland.

Overview

Laxxon Medical

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Events

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Laxxon Medical

CB Rank

333028

Laxxon Medical is a biotechnology company.

Founded

obfuscation

Private

Zürich, Zurich, Switzerland

1-10

www.laxxon-medical.com

Biotechnology

Industrial Engineering

Printing

Key People

Alexander Ruckdaeschel: Chief Strategy Officer Board member
Past Role: Emstory, Co founder/Board Member

Details

Legal Name

Laxxon Medical Ltd.

Operating Status

Active

Company Type

For Profit

About the Company

Laxxon Medical is a disruptive biotech startup whose 3-D printing technology is transforming the pharmaceutical industry. Laxxon Medical owns the exclusive rights to the development, production, and commercialization of innovative drug delivery systems on the basis of a worldwide patented large-scale 3D screen printing.

Phone Number

+41 56 484 5539

Contact Email

info@laxxon-medical.com

Predictions & Insights

Growth Insight

See this Growth Insight

Laxxon Medical is

Lorem

to be growing

Top Contributing Factors

Operations Expansion

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Growth Insight

Products & Services

SPID®-Technology

A patented 3D screen printing additive manufacturing process for producing oral, transdermal, and implantable drug delivery systems with tailored release profiles and complex drug geometries.

LXM.5 Levodopa/Carbidopa Treatment

A 3D screen-printed oral tablet formulation for Parkinson’s disease that improves bioavailability and provides controlled, sustained levodopa release.